
Botulinum Toxin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), End User (Specialty and D
Description
Botulinum Toxin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), End User (Specialty and Dermatology Clinics, Hospitals and Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
According to our latest study on Botulinum Toxin Market Forecast to 2031 – Global Analysis – by Product, Application, and End User the market was valued at US$ 7.38 billion in 2023 and is expected to reach US$ 19.03 billion by 2030. It is estimated to register a CAGR of 12.6% from 2023 to 2031.
Botulinum toxins are neurotoxins produced by bacteria named Clostridium botulinum. After the toxin is injected into a muscle, it blocks nerve signals to the muscle, thereby blocking its contraction and reducing unwanted facial lines or features. Botulinum toxin injections such as Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.
Noninvasive procedures of facial rejuvenation using injections of botulinum toxin, calcium hydroxylapatite, and hyaluronic acid, among others. These procedures have minimal side effects and help reduce cellulite, wrinkles, facial lines, and unwanted fat. The concept of natural rejuvenation is based on a comprehensive, multilayered, three-dimensional approach that combines multiple techniques and active ingredients in procedures such as volume enlargement, skin relaxation, reshaping, volume repositioning, skin tightening, and surface renewal, depending on specific needs of patients. The most often used non-surgical face procedures are chemical peels, laser skin resurfacing, soft tissue fillers, and Botox. Unlike surgical procedures that are associated with greater risks, minimally invasive procedures benefit patients through faster recovery, lesser scarring, limited stress, and better patient satisfaction. Moreover, changing consumer views about wellness, beauty, and good aging results in a better understanding and acceptance of aesthetics worldwide. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the number of nonsurgical procedures increased by 19.9% in 2021 compared to 2020. The total number of nonsurgical procedures was 17.5 million in 2021. Thus, an upsurge in the adoption of noninvasive aesthetic procedures is driving the growth of the botulinum toxin market.
By Application, Botulinum Toxin Market-Based Insights
The botulinum toxin market, by application, is bifurcated into medical and aesthetic. The medical segment held the largest botulinum toxin market share in 2023 and is anticipated to register the highest CAGR of 13.3% during 2023–2031. The medical segment is further categorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. The market for the aesthetic segment is further divided into frown lines/ glabellar, forehead lines, crow’s feet, square jaw/ masseter, and others. Botulinum toxin is a neurotoxin used to treat and manage various medical conditions, including chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity. Medical applications of botulinum toxin include chronic migraine, muscle spasms, overreactive bladder, and hyperhidrosis. Chronic migraine is a severely disabling neurological disorder characterized by pulsating unilateral or bilateral headaches. It is primarily described as a headache that troubles individuals for at least 15 days per month for three months. Botulinum toxin injections have also been found to be effective in treating cerebral palsy, providing patients with major relief from severe muscle contraction. Botulinum toxin A has also been studied for its effectiveness in treating chronic lower back pain.
By End User, Botulinum Toxin Market-Based Insights
In terms of type, the botulinum toxin market is categorized into specialty and dermatology clinics, hospitals and clinics, and others. The specialty and dermatology clinics segment held the largest market share in 2023. The botulinum toxin market growth in this segment is attributed to the patients’ inclination toward dermatology clinics for their specialized dermatology treatment needs, and the ability of these clinics to provide rapid and effective services. These patients usually have specific skin conditions that require expert evaluation and management. Botulinum toxin treatments offered in dermatology clinics are tailored to address these specific concerns, with customized formulations designed to target the underlying causes of skin problems. Cosmetic procedures have become more widespread in the last 10 years. Moreover, the introduction of minimally invasive techniques has added to the popularity of dermatological procedures. Botulinum toxin injections, hyaluronic acid treatments, laser hair removal, nonsurgical fat reduction, and photorejuvenation/intense pulse light (IPL) have been the most common nonsurgical cosmetic procedures that are performed in dermatology clinics.
International Society of Aesthetic Plastic Surgery, and National Institute for Health and Care Excellence are a few of the major secondary sources referred to while preparing the report on the botulinum toxin market.
Reasons to buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global botulinum toxin market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global botulinum toxin market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook in North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America coupled with the factors driving the market, as well as those hindering it.
Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Please Note: It will take 3-5 business days tocomplete the report upon order confirmation for delivery of the full report andexcel data pack. for on demand reports
Table of Contents
381 Pages
- 1. Introduction
- 1.1 Scope of the Study
- 1.2 Market Definition, Assumptions and Limitations
- 1.3 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 2.2 Market Attractiveness Analysis
- 3. Research Methodology
- 4. Botulinum Toxin Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
- 5. Botulinum Toxin Market - Key Market Dynamics
- 5.1 Key Market Drivers
- 5.2 Key Market Restraints
- 5.3 Key Market Opportunities
- 5.4 Future Trends
- 5.5 Impact Analysis of Drivers and Restraints
- 6. Botulinum Toxin Market - Global Market Analysis
- 6.1 Botulinum Toxin - Global Market Overview
- 6.2 Botulinum Toxin - Global Market and Forecast to 2031
- 7. Botulinum Toxin Market – Revenue Analysis (USD Million) – By Product, 2021-2031
- 7.1 Overview
- 7.2 Botulinum Toxin A
- 7.3 Botulinum Toxin B
- 8. Botulinum Toxin Market – Revenue Analysis (USD Million) – By Application, 2021-2031
- 8.1 Overview
- 8.2 Medical
- 8.2.1 Chronic Migraine
- 8.2.2 Muscle Spasm
- 8.2.3 Over Reactive Bladder
- 8.2.4 Hyperhidrosis
- 8.2.5 Others
- 8.3 Aesthetic
- 8.3.1 Crow’s Feet
- 8.3.2 Forehead Lines
- 8.3.3 Frown Lines/ Glabellar
- 8.3.4 Square Jaw/ Masseter
- 8.3.5 Others
- 9. Botulinum Toxin Market – Revenue Analysis (USD Million) – By End User, 2021-2031
- 9.1 Overview
- 9.2 Specialty and Dermatology Clinics
- 9.3 Hospitals and Clinics
- 9.4 Others
- 10. Botulinum Toxin Market - Revenue Analysis (USD Million), 2021-2031 – Geographical Analysis
- 10.1 North America
- 10.1.1 North America Botulinum Toxin Market Overview
- 10.1.2 North America Botulinum Toxin Market Revenue and Forecasts to 2031
- 10.1.3 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Product
- 10.1.4 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Application
- 10.1.5 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By End User
- 10.1.6 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Countries
- 10.1.6.1 United States Botulinum Toxin Market
- 10.1.6.1.1 United States Botulinum Toxin Market, by Product
- 10.1.6.1.2 United States Botulinum Toxin Market, by Application
- 10.1.6.1.3 United States Botulinum Toxin Market, by End User
- 10.1.6.2 Canada Botulinum Toxin Market
- 10.1.6.2.1 Canada Botulinum Toxin Market, by Product
- 10.1.6.2.2 Canada Botulinum Toxin Market, by Application
- 10.1.6.2.3 Canada Botulinum Toxin Market, by End User
- 10.1.6.3 Mexico Botulinum Toxin Market
- 10.1.6.3.1 Mexico Botulinum Toxin Market, by Product
- 10.1.6.3.2 Mexico Botulinum Toxin Market, by Application
- 10.1.6.3.3 Mexico Botulinum Toxin Market, by End User
- Note - Similar analysis would be provided for below mentioned regions/countries
- 10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
- 10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
- 10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
- 10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America
- 11. Industry Landscape
- 11.1 Mergers and Acquisitions
- 11.2 Agreements, Collaborations, Joint Ventures
- 11.3 New Product Launches
- 11.4 Expansions and Other Strategic Developments
- 12. Competitive Landscape
- 12.1 Heat Map Analysis by Key Players
- 12.2 Company Positioning and Concentration
- 13. Botulinum Toxin Market - Key Company Profiles
- 13.1 AbbVie Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- Note - Similar information would be provided for below list of companies
- 13.2 Merz Pharma
- 13.3 Aquavit Holdings
- 13.4 Evolus, Inc
- 13.5 Ipsen Pharma
- 13.6 Medytox Inc.
- 13.7 GALDERMA
- 13.8 HUGEL, Inc.
- 13.9 Revance Therapeutics Inc
- 13.10 Lanzhou Institute of Biological Products Co Ltd
- 14. Appendix
- 14.1 Glossary
- 14.2 About The Insight Partners
- 14.3 Market Intelligence Cloud
- LIST OF TABLES
- Table 1. Botulinum Toxin Market Segmentation 27
- Table 2. Nonsurgical Procedures, by Country, 2021 34
- Table 3. Global Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 44
- Table 4. Global Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 45
- Table 5. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 52
- Table 6. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 52
- Table 7. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 52
- Table 8. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 53
- Table 9. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 53
- Table 10. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 55
- Table 11. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 55
- Table 12. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 56
- Table 13. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 56
- Table 14. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 56
- Table 15. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 57
- Table 16. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 58
- Table 17. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 58
- Table 18. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 58
- Table 19. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 59
- Table 20. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 60
- Table 21. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 61
- Table 22. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 61
- Table 23. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 61
- Table 24. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 62
- Table 25. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 65
- Table 26. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 65
- Table 27. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 65
- Table 28. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 66
- Table 29. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 66
- Table 30. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 68
- Table 31. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 68
- Table 32. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 69
- Table 33. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 69
- Table 34. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 70
- Table 35. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 72
- Table 36. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 72
- Table 37. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 72
- Table 38. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 73
- Table 39. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 73
- Table 40. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 74
- Table 41. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 75
- Table 42. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 75
- Table 43. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 75
- Table 44. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 76
- Table 45. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 77
- Table 46. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 78
- Table 47. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 78
- Table 48. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 78
- Table 49. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 79
- Table 50. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 80
- Table 51. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 81
- Table 52. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 81
- Table 53. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 81
- Table 54. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 82
- Table 55. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 83
- Table 56. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 84
- Table 57. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 84
- Table 58. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 85
- Table 59. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 85
- Table 60. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 88
- Table 61. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 88
- Table 62. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 88
- Table 63. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 89
- Table 64. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 89
- Table 65. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 91
- Table 66. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 91
- Table 67. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 92
- Table 68. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 92
- Table 69. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 93
- Table 70. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 95
- Table 71. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 95
- Table 72. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 95
- Table 73. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 96
- Table 74. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 96
- Table 75. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 97
- Table 76. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 98
- Table 77. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 98
- Table 78. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 98
- Table 79. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 99
- Table 80. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 100
- Table 81. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 100
- Table 82. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 101
- Table 83. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 101
- Table 84. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 102
- Table 85. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 103
- Table 86. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 104
- Table 87. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 104
- Table 88. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 104
- Table 89. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 105
- Table 90. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 106
- Table 91. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 107
- Table 92. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 107
- Table 93. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 107
- Table 94. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 108
- Table 95. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 110
- Table 96. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 110
- Table 97. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 111
- Table 98. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 111
- Table 99. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 112
- Table 100. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 113
- Table 101. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 114
- Table 102. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 114
- Table 103. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 114
- Table 104. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 115
- Table 105. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 116
- Table 106. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 117
- Table 107. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 117
- Table 108. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 118
- Table 109. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 118
- Table 110. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 119
- Table 111. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 120
- Table 112. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 120
- Table 113. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 120
- Table 114. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 121
- Table 115. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 123
- Table 116. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 123
- Table 117. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 123
- Table 118. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 124
- Table 119. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 124
- Table 120. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 126
- Table 121. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 126
- Table 122. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 127
- Table 123. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 127
- Table 124. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 128
- Table 125. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Country 128
- Table 126. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 130
- Table 127. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 130
- Table 128. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 130
- Table 129. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 131
- Table 130. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 131
- Table 131. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 132
- Table 132. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 133
- Table 133. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 133
- Table 134. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 133
- Table 135. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 134
- Table 136. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 135
- Table 137. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 136
- Table 138. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 136
- Table 139. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 137
- Table 140. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 137
- Table 141. Recent Inorganic Growth Strategies in the Medical Ultrasound Flow Meter Market 139
- Table 142. Recent Organic Growth Strategies in the Medical Ultrasound Flow Meter Market 139
- Table 143. Glossary of Terms 173
- LIST OF FIGURES
- Figure 1. Botulinum Toxin Market Segmentation, by Geography 27
- Figure 2. PEST Analysis 32
- Figure 3. Impact Analysis of Drivers and Restraints 36
- Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2023–2031 37
- Figure 5. Global Botulinum Toxin Market, By Geography Forecast Analysis, 2023 & 2031 38
- Figure 6. Botulinum Toxin Market Share (%) – by Product (2023 and 2031) 39
- Figure 7. Botulinum Toxin A: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 40
- Figure 8. Botulinum Toxin B: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 41
- Figure 9. Botulinum Toxin Market Share (%) – by Application (2023 and 2031) 42
- Figure 10. Medical: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 43
- Figure 11. Aesthetic: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 44
- Figure 12. Botulinum Toxin Market Share (%) – by End User (2023 and 2031) 46
- Figure 13. Speciality and Dermatology Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 47
- Figure 14. Hospitals and Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 48
- Figure 15. Others: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 49
- Figure 16. North America: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 50
- Figure 17. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 51
- Figure 18. North America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 54
- Figure 19. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 55
- Figure 20. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 57
- Figure 21. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 60
- Figure 22. Europe: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 63
- Figure 23. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 64
- Figure 24. Europe: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 67
- Figure 25. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 68
- Figure 26. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 71
- Figure 27. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 74
- Figure 28. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 77
- Figure 29. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 80
- Figure 30. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 83
- Figure 31. Asia Pacific: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 86
- Figure 32. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 87
- Figure 33. Asia Pacific: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 90
- Figure 34. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 91
- Figure 35. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 94
- Figure 36. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 97
- Figure 37. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 100
- Figure 38. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 103
- Figure 39. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 106
- Figure 40. Middle East and Africa: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 109
- Figure 41. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 110
- Figure 42. Middle East and Africa: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 112
- Figure 43. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 113
- Figure 44. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 116
- Figure 45. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 119
- Figure 46. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 122
- Figure 47. South and Central America: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 125
- Figure 48. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 126
- Figure 49. South and Central America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 128
- Figure 50. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 129
- Figure 51. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 132
- Figure 52. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 135
- Figure 53. Growth Strategies in the Medical Ultrasound Flow Meter Market 138
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.